DAWNZERA Trademark
Trademark Overview
On Monday, June 5, 2023, a trademark application was filed for DAWNZERA with the United States Patent and Trademark Office. The USPTO has given the DAWNZERA trademark a serial number of 98027561. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, September 25, 2024. This trademark is owned by Ionis Pharmaceuticals, Inc.. The DAWNZERA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; providing medical and scientific research and medical and scientific research information in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; compiling data for research purposes in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders
General Information
| Serial Number | 98027561 |
| Word Mark | DAWNZERA |
| Filing Date | Monday, June 5, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Wednesday, September 25, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 22, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical research and development in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; providing medical and scientific research and medical and scientific research information in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; compiling data for research purposes in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, July 9, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Ionis Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Carlsbad, CA 92010 |
| Party Name | Ionis Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Carlsbad, CA 92010 |
Trademark Events
| Event Date | Event Description |
| Thursday, June 8, 2023 | NEW APPLICATION ENTERED |
| Sunday, July 9, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 18, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, July 18, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 2, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 22, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 22, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 17, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 12, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, March 12, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, March 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 25, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 25, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 25, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, September 25, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, September 25, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 25, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, September 25, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 25, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, September 25, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, September 25, 2024 | SOU EXTENSION 2 GRANTED |
